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Sickle Cell Anemia and Pain Crisis: Empowerment by Self-monitoring 
Background 
 
In the United States nearly a million people are living with Sickle Cell Disease (SCD) or 
Sickle Cell Trait; one in 365 African Americans lives with SCD and one in thirteen African 
Americans is born with SCD trait (Capriotti & Frizzell, 2016; CDC, n.d).  Those with SCD often 
experience unpredictable pain crises that require emergency care and may result in 
hospitalization (Matthie, Jenerette, & McMillan, 2015). The debilitating effects of SCD 
significantly decrease quality of life (e.g., chronic and intermittent pain, frequent need for 
medical attention, inability to engage in active hobbies or employment, and threat of serious 
complications). Further, individuals with SCD experience higher rates of infection and organ 
damage and significantly shorter life spans then those without SCD (Capriotti & Frizzell, 2016).  
Although improved treatment has resulted in greater increased life expectancy from an average 
of 14 years in the 1970’s, to beyond 40 years today, the grave complications associated with 
SCD significantly shorten the average lifespan of individuals with SCD twenty to thirty years 
shorter when compared to those with normal red blood cells (Agodoa, Lubeck, Bhakta, Danese, 
Pappu, Howard, … & Lanzkron, 2018; Ballas, S.K., Pulte, E.D., Lobo, C., & Riddick-Burden, 
G., 2016). Those experiencing the painful and misunderstood effects and complications of SCD 
are now expected to live longer, thus require additional resources and confidence to manage their 
disease into adulthood and in doing so, fostering a better quality of life. Self-care strategies (e.g., 
maintaining adequate hydration, healthy diet, and rest) may mitigate pain crises and subsequently 
reduce the need to seek health care intervention (Lee, Askew, Walker, Stephen, & Robertson-
Artwork, 2012).  
Pathophysiology 
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SCD is a common disease caused by the mutation of a gene affecting the synthesis and 
substitution of a single amino acid in red blood cell production. The resulting varied protein 
chain disrupts the oxygen binding process, leads to longer polymerization of supple red blood 
cells that then deform into rigid, inflexible, elongated, sickle shaped cells. This deformation is 
provoked by hypoxia and dehydration (Brandow, Zappia, & Stuckly, 2018). The sickling and 
adhesion of sickled molecules depends upon blood density and occurs predominantly during low 
shear conditions. Sheer stress is the force of blood against the endothelial lining as it perforates 
vessels. (Barbanio, Platt, & Kaul 2010; Lanotte, Mauer, Mendez, Fedosov, Fromental, Claveria, 
Nicoud, Gompper, & Abkarian, 2016). Adhesion and clustering of the crescent shaped red cell 
within blood vessels results in extreme pain, decreased functionality of the spleen, risk for 
infection, and long term damage to the heart, kidneys, liver, gallbladder, and retinas (Vaishya, 
Agarwal, Edomwonyi, & Vijay, 2015).  
As a hematological disease, SCD impacts the function of each organ system and thus 
creates long term harm to any organ system. Those with SCD are at a significantly higher risk for 
stroke and silent cerebral infraction due to SCD induced ischemia, (Strouse, Lanzkron & Urrutia, 
2011). 11% of children and adolescence will have a stroke by the age of twenty and 20% of 
adults will have a stroke by the age of 45 (Pack-Mabien & Haynes, 2009). Cell aggregation 
within capillaries effects the eyes leading to blindness, retinopathy, and hemorrhage, (Capriotti 
& Frizzell, 2016). Distress to the musculoskeletal system is due to avascular necrosis in large 
joints, osteomyelitis, and dactylitis. Abdominal pain, hepatomegaly, splenomegaly, and 
gallstones cause immense pain and splenic sequestration, placing individuals in an 
immunocompromised state, opening the opportunity to many different forms of infection (NIH, 
2018). Many individuals are admitted to acute care settings with pulmonary illnesses related to 
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SCD such as pneumonia, acute chest syndrome, pulmonary hypertension, and atelectasis 
(Knight-Madden & Greenough, 2014).  Renal abnormalities in patients with SCD cause the 
kidneys to be less effective at maintaining proper fluid balance. The dysfunction of a key 
compensatory mechanism can leave patients more susceptible to dehydration due to the loss of 
free water even when oral hydration is maintained (Sharpe & Thein, 2014).  Accurately 
monitoring hydration levels provides the potential to reduce the severity, frequency, and duration 
of sickle cell pain crisis. Increasing mortality among individuals with SCD is directly related to 
the number of occurrences and frequency of crisis, (Brandow, Zappia, & Stucky, 2017). 
Sickle Cell Pain 
The spectrum of SCD pain ranges from mild to severe and is commonly misunderstood 
by caregivers and clinicians. A patient may experience an unpredictable exacerbation of acute 
pain or consistent and intermittent chronic pain, (Brandow, Zappia, & Stucky, 2017).  There are 
two types of pain that influence the extreme discomfort felt during a crisis.  Nociceptive pain, 
refers to the tissue damage caused by ischemia. Neuropathic pain refers to peripheral nervous 
system damage (Ballas, 2011). Unfortunately, most individuals experience both acute and 
chronic pain and well as nociceptive and neuropathic pain simultaneously. This results in debility 
and an inability to participate in activities of daily living, family roles, employment and even 
hobbies (Kanter, 2018). 
Link to Hydration 
Hospital treatment is often sought in times of severe pain to obtain analgesics, medical 
attention during a time of infection susceptibility, treatment of complications, and to rehydrate 
with fluids. Ample hydration is necessary to avoid and reverse a hyperviscous sickled state, 
(Trippette, Loko, & Samb, 2010).  Red blood cell suppleness promotes uninterrupted navigation 
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through narrow vessels and effective deliver oxygen throughout the body.  In the presence of 
dehydration, red blood cells are at increased risk for sickling or if sickled, remain so for 
prolonged periods of time (Okomo & Meremikwi, 2015).  Rigid red blood cells aggregate 
intravascularly, creating hyperviscuous, or thickened, blood that potentially worsen and prolong 
clinical symptoms (Li, Du, Lei, Tang, Dao, Suresh, & Karniadakis, 2015). Even when oxygen 
tension is normal, cell dehydrated prolongs the sickled state (Brugnara, 1995). Therefore, 
adequate hydration is thought to reduce hyperviscosity and its associated clinical risks (Trippette, 
Loko, & Samb, 2010).  Upon precipitation of a pain crisis, analgesics along with fluids are 
cornerstone treatments (DeBaun, & Vichinsky, 2018). 
Treatment priorities for pain crises include pain control, increased hydration and adequate 
oxygenation (DeBaun & Vichinsky, 2018). During a pain crisis, dehydration of red blood cells 
promotes and prolongs sickling (Okomo & Meremikwi, 2015). Once dehydrated red blood cells 
sickle, they remain sickled even in the presence of normal oxygen tension (Brugnara, 1995). 
Increasing hydration is thought to reduce hyperviscosity caused by sickled red blood cells and, in 
turn, improve circulation and oxygen delivery (Trippette, Loko, & Samb, 2010). Therefore, 
accurate assessment of hydration levels and early intervention may provide an opportunity to 
reduce the frequency, severity, and duration of sickle cell pain crisis. Since those with SCD have 
an attenuated thirst drive, emerging wearable monitoring technology may be useful for early 
identification of dehydration and early reversal of dehydration that leads to crisis prevention. The 
purpose of this study is to describe the signs and symptoms adults with SCD associate with an 
emerging pain crisis, identify the self-care strategies adults with SCD use to mitigate a crisis; and 
explore individuals with Sickle Cell Disease interest in using wearable technology to monitor 
their health status.   
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Technology-Enabled Hydration Monitoring 
 Consumers, providers, and insurance companies alike share a desire to track health 
patterns in hopes for early recognition, prevention, improved treatment and management. The 
number of devices to monitor oxygen saturation, calories burned, physical activity, heart rate 
variability, UV exposure, and blood sugar levels noninvasively from the surface of the skin have 
grown significantly. Connections to phone and computer applications make these results 
trackable and are an asset to the user as well as providers, who desire a better understanding of 
specific physiologic parameters. Access to this information may promote a more personalized 
approach to prevention and management of chronic illnesses.   
Bioelectric Impedance Analysis, defined as skin surface assessment of high and low 
frequency AC current, is thought to be the most accurate and useful method to rapidly and non-
invasively measure hydration (Garrett, Rae, Fletcher, Zarnke, Thorson & Hoges, 2018). As 
illustrated in Figure 1, low frequency currents are theorized to travel only in extracellular fluid 
while it is hypothesized that high frequency current travels through both extracellular fluid and 
intracellular fluid.  A pair of bioelectrode sensors placed on the skin’s surface measures 
differences in resistance between the two sensors, and then again between the high and low 
frequency currents, and can provide information on the fluid content of the epidermis (Garrett, et 
al., 2018).   
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Figure 1. Hypothesized path of high and low frequencies used for Bio-impendence 
analysis 
 
Available textile materials are favorable for imbedding this technology due to factors related to 
accuracy, durability, flexibility and comfort. To achieve a stretchable and mechanically robust 
product silver is used as a highly conductive fiber along with a mix of polymers with high tensile 
strength and strain rate (Garrett, et al., 2018). Bioimpedance analysis is a favorable technique to 
capture hydration status. Imbedded within a comfortable textile material, bioimpedance analysis 
accurately measures changes in the epidermal skin layer caused by fluctuating hydration, and is 
not effected by the external environment.  
Exploring the value of weaving conductive threads into a textile device offers advances 
in monitoring technology, comfort, and durability. Use of conductive threads offers the 
opportunity to utilize resistance measurements between the threads, (Jia, Xu, Pan, Xia, Wei, 
Noh, Zhang & Jiang, 2018). The resistance between threads will vary based on the amount of 
sweat absorbed. Figure 2 illustrates cotton, a highly absorptive textile material wrapped around 
braided conductive threads to create a path for sweat to flow past the threads, (Jia, et al., 2018). 
 
Figure 2. Braided conductive threads wrapped with cotton thread 
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The effectiveness of this type of technology, relies solely on absorbing sweat and is sensitive to 
sensor body placement and location. However, it is easily woven, worn, and adapted into 
everyday life with minimal effort.  
Another mechanism for quantifying hydration levels captures and evaluates the chemical 
composition of perspiration.  The basic principles of perspiration analysis originate from the 
conventional method of collecting perspiration from gauze and analyzing the chemical 
composition of the collected fluid. Determining the concentration of a chemical or chemicals 
within a solution using light wavelength absorption analysis is referred to as colorimetric 
analysis, (Encyclopedia Britannica, 2019). A device released for human trials in January 2019 
relies on colorimetrics, volume, and electrochemical analysis that through a disposable porous 
patch, redirects perspiration into the durable and reusable module. Sweat passes over collection 
chambers, mixes with dye, and then analyzed to determine hydration level. Figure 3 displays the 
concept of the device starting from product assembly, body adhesion, and link to application on a 
mobile device (Bandodkar, Gutruf, Choi, Lee, Sekine, Reeder, Jeang, Aranyosi, Lee, Model, 
Ghaffari, Su, Leshock, Ray, Verrillo, Thomas, Krishnamurthi, Han, Kim, Krishnan, Hang & 
Rogers, 2019).  
 
Figure 3. Concept of wearable colorimetric analysis device 
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Continuously wearing this type of device may benefit patients as they enter a crisis and or 
as they actively attempt to increase hydration levels. In its current design, this device would not 
continuously gather data and monitor hydration prophylactically, since is not designed with the 
intention of everyday wear. This method of hydration assessment has been imbedded within a 
woven cotton thread that absorbs fluid and channels it to the collection module for analysis.  
Although the end product is more wearable, durable, and reusable, it lacks a user interface (e.g., 
watch) to display analysis results directly to the user-wearer. Further, hydration monitors must 
remain reliable in the face of fluctuating humidity and variations in sweat pore distribution.  
Product Development 
Framework  
 Known as the Three P’s, three forces drive the development and success of medical 
devices: providers, patients, and payers (Figure 4). Providers must critically evaluate the 
monitoring parameters and data accuracy of a product, and then judge if the device will improve 
their patients’ health outcomes. Patients determine if the device will help them monitor and 
manage their condition toward attaining health goals, improving outcomes, and possibly 
decreasing pain. A patient also identifies external and internal barriers to product use. Payers 
(i.e., healthcare systems or insurance companies) identify future cost savings that may occur as a 
result of device use: reduced readmissions, length of stay, health care utilization and comorbidity 
exacerbation. Insurance companies serve as gate keepers for reimbursement levels, coverage 
parameters, and even patient accessibility. Each of the Three Ps influence each other and impact 
the long-term success of a product.  
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Figure 4. Diagram illustrating the Three P’s interaction with each other and the final product. 
Business Canvas Model  
 The business canvas model is a comprehensive, widely used tool for identifying the value 
a product might add to communities and individuals’ lives. From identified value, the model 
(Figure 5) expands to identify potential customers, methods for developing customer 
relationships, and appropriate communication channels for contacting customers, (Jur, J. 
Personal Communication. 2018).  A business canvas model also specifically lists customer 
groups as a tool for identifying customer needs during product development. Primary potential 
customers include individuals with SCD and their care providers as well as health care providers, 
healthcare systems, and insurance companies. Potential personal and economic benefits might 
include reduced incident, frequency and severity of pain crises (patient value), improved health 
outcomes (provider value), and decreased health utilization (payer value). Once value and 
customers are identified, the business canvas model then guides users toward effective methods 
for building and maintaining customer rapport (i.e., trainings, SMART (utilizes phone and 
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computer applications to store and display physiological data) device logging, alerts on the 
device, or symptom monitoring) and their associated delivery channels (i.e., support groups, 
health clinic, provider prescription, medical device conferences, sickle cell disease journals and 
conferences, and virtual demonstrations). Organizing the scope of a medical device’s influence 
guides many of the important decisions made by a device development company.   
 
Figure 5. Business Canvas Model for a SCD Device Example 
Gaining Approval and Product Development 
Health device development companies invest significant resources in establishing the safety and 
efficacy of their products. In 2014, it cost an average of thirty-one million dollars bring a medical 
device to market, (Buntz, 2016). Therefore, companies employ a team of experienced regulatory 
coordinators to develop and execute an efficient plan-to-market strategy. The product 
development process begins with a thorough strategy to gain Federal Drug Administration 
(FDA) approval. Products fall into one of three categories primarily based upon user risk: Class 
I, minimal risk  (i.e., bandages), Class II, low to moderate risk (i.e., infusion pumps), and Class 
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III, high risk (i.e., implantable defibrillators) (FDA, 2018). Today, 47% of medical devices are 
Class I; 95% of these are exempt from regulatory process, (BMP Solutions, 2019). Following 
approval by the FDA, a company seeks human subjects research approval to assess a devices’ 
efficacy through a clinical trial research study. Patient outreach, focus groups, and interviews are 
essential to identifying participants for a clinical trial. Finally, a company develops support 
among payers by developing a payment algorithm with hospitals and insurance companies based 
on price, patient necessity, and cost benefits.  Due to the complexity within the medical arena, a 
more thorough a plan is prepared in the preliminary stages of product development, the faster a 
product will be in use.   
Methods 
Guided by the business canvas model, the purpose of this project was to: (1) describe the signs 
and symptoms adults with SCD associate with an emerging pain crisis; (2) identify the self-care 
strategies adults with SCD use to mitigate a crisis; and (3) explore adults with SCD interest in 
using wearable technology to monitor their health status. The project received human subjects 
research approval from the University of North Carolina at Chapel Hill Institutional Review 
Board.  
Participant Recruitment 
A cross-section of members from the online support community, OneSCDvoice 
(https://www.onescdvoice.com/), were recruited to complete an anonymous online questionnaire. 
The OneSCDVoice online community was developed as a digital education and collaboration 
platform for those interested in the care of SCD patients.  At present the site serves the 
community as an outlet to connect through the site’s SMART Social Wall, stay up to date with 
current research, and serves a community of researchers.  All adult individuals with SCD, 
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Family/Friend (caregiver), Healthcare Providers, Media/Health Communicators, Medical/Health 
Student, Advocates, and Researchers were eligible to participate.  
Following analysis of existing SCD research studies assessing subjects’ experiences with 
pain, hydration, and physical activity (study participants ranged from n=10 to n=30), fifteen 
adults above the age of 18 with SCD we deemed a sufficient number to achieve study aims, 
(Alleyen & Thomas, 1994; Brandow, Zappia & Stucky, 2017; Evensan, Treadwell, Keller, 
Levine, Hassell, … & Smith, 2016; Gregory, 2012; Jacob, Stinson, Duran, Gupta, … & Zelter, 
2012; Jenerette & Lauderdale, 2008; Karlson, Baker, Bromberg, Elkin, Majumdar & Palermo, 
2017; Okomo & Meremikwu, 2017; Shah & De Castro, 2014).    
Data Collection 
Open-ended survey questions (Table 1) were developed based upon available literature 
and designed to elicit participants’ perceptions about signs and symptoms of pain crisis, self-care 
strategies, and openness to self-monitoring.  
Table 1. Survey Questions 
• Please describe the signals, signs, or symptoms you experience that let you know a pain 
crisis is coming.  
• Please think about a time when you had early warning of an approaching pain crisis. How 
much time did you have between that early warning and a full-blown pain crisis? 
• From your personal experience, do you feel there is a relationship between how much 
water you drink and the pain and severity of your crisis? 
• What actions do you take to prevent pain crises from occurring? 
• Once you get an early warning that a pain crisis might occur, what actions do you take to 
prevent a full-blown crisis or reduce the severity of a full-blown pain crisis? 
• Once you are experiencing a full-blown pain crisis, what actions do you take to resolve the 
crisis? 
• Apple ™ recently released a new watch that monitors heart rhythms to detect atrial 
fibrillation, a potentially deadly dysrhythmia. If there was a similar, wearable technology 
for individuals with sickle cell disease what signals, symptoms or signs you would want 
the technology monitor? 
• Because atrial fibrillation can occur at any time, patients at risk for this problem will likely 
need to wear the Apple watch continuously. What daily tasks might prevent you from 
wearing a SCD monitoring technology, such as a shirt, wristband, or watch? 
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• If a wearable technology were able to warn you of an approaching crisis what actions 
might you take to prevent the crisis? 
Demographic Data 
Study results suggest that symptoms may differ by gender and self care strategies may 
differ by age, therefore, participants were asked to self-disclose age (in years), and gender (male, 
female, do not wish to disclose). Finally, because the study was advertised on the OneSCDVoice 
Social wall, open to all members of the community, all participants were asked to self-identify 
their SCD role using the OneSCDVoice member categories (i.e., Individual with SCD, 
Family/Friend (caregiver), Healthcare Provider, Media/Health Communicator, Medical/Health 
Student, Advocate Researcher, Other Role in SCD). 14 respondents opened the survey: four did 
not answer any questions, three provided demographic data and seven completed the entire 
survey. Participants were primarily female and ranged in age from 32 to 59 years old (M=42.8) 
(Table 2).  
Table 2.  
Participant demographics. 
Characteristics Participants (n=10) 
Age (years) 42.8 (32-59) 
Male gender  3 (30) 
SCD role (Adult with SCD) 10 (100) 
Completed survey 7 (70) 
Following UNC IRB approval, a recruitment advertisement was posted on the OneSCDVoice 
SMART social wall on Monday February 4th at 4pm (Figure 6).   
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Figure 6. OneSCDvoice participant recruitment post 
 
Once a participant clicked on the link, they proceeded to a consent page and gave consent 
(Figure 7) by clicking the link ‘Proceed to Survey”.   
The purpose of this research study is to achieve a more comprehensive understanding of 
(1) individuals with Sickle Cell Disease awareness about an approaching pain crisis, (2) 
the strategies individuals with Sickle Cell Disease use to manage their pain crisis; and (3) 
explore individuals with Sickle Cell Disease interest in using wearable technology (for 
example: watches, wristbands, or shirts) to monitor their health status.   
 
You are being asked to take part in this research study because of your knowledge about 
sickle cell disease, your experiences before and during a pain crisis, and your 
management of pain crisis.  
 
You must be at least 18 years old to participate.  
 
Participation in this research study is completely voluntary. You may choose not to be in 
this research study. You may choose not to answer any individual question or to not 
complete the survey. Your participation in this study has no impact on care you receive or 
might receive at the University of North Carolina Health System. 
  
If you agree to take part in this research, you will be asked to complete 3 questions about 
yourself, including age and gender and to answer nine questions about your experiences 
with SCD. Although questions in the survey are similar to those routinely asked by health 
care providers, participants may experience unpleasant emotions associated with recalling 
SCD pain crisis. There is no monetary compensation for participation, however 
“Hello all, 
I am a nursing student at UNC-Chapel Hill and have been studying sickle cell disease. 
Reading my textbook and journals only provides the surface of information, so this is why I 
would like to hear from you, in your words and from your own life experience. I am 
conducting a research study to better understand the experience of a sickle cell patient who is 
enduring a pain crisis and the link to hydration. I would like to gain more knowledge on how 
an individual with sickle cell disease manages their chronic illness, how you anticipate that a 
pain crisis may occur, and what interventions work best for you. Also, if there was an 
application or device to monitor your illness best, what features would it possess? The survey 
should take five to ten minutes to complete, will not ask any identifiable information, and 
your answers will only be available to me and faculty advisor and will be username and 
password protected in a UNC School of Nursing server. There will be no compensation for 
this survey. Please click on the following link if you would like to contribute to my study and 
understanding of your disease. 
https://unc.az1.qualtrics.com/jfe/form/sv_5jrxezk7zqvu8vt”  
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participants may value contributing to greater knowledge about SCD pain management. 
Your participation in this survey will take approximately ten to fifteen minutes to 
complete.  
 
To protect your identity as a research subject, no identifiable information will be 
collected.  
 
If you have any questions about this research, please contact the Investigator by emailing 
salibak@live.unc.edu . If you have questions or concerns about your rights as a research 
subject, you may contact the University of North Carolina at Chapel Hill Institutional 
Review Board at 919-966-3113 or by email to IRB_subjects@unc.edu. 
Clicking “Proceed to the survey” implies that you agree to the consent above. 
 
Figure 7. Consent statement. 
Data Analyses 
Qualitative content analysis was used to code responses and identify themes with a goal 
to answer study aims. The first recruitment post received 3 “cares” and one “thanks”, however 
this advertisement only generated one complete survey. The second recruitment post was 
shortened and published to the SMART Social Wall on Sunday February 17, at 12pm, earlier in 
the day and on a weekend, on the premise that individuals were more likely to participate in 
online activity on a weekend. The second recruitment post generated six views and five survey 
responses. A final recruitment post, announcing survey closure, was published on a Friday 
morning, March 1st. This yielded five views and three more survey responses.  
Survey Responses 
Survey respondents identify pain as the initial signal to an oncoming pain crisis (Figure 
8).  
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Figure 8. Please describe the signals, signs, or symptoms you 
experience that let you know a pain crisis is coming. 
 
The majority of respondents reported that they know a pain crises is coming more than an hour 
in advance (Figure 9).  
 
 
Figure 9.  How much time did you have between that early 
warning and a full-blown pain crisis? 
 
Five of seven respondents linked fluid consumption with the severity of their pain during a crisis 
(Figure 10).  
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Figure 10.  From your personal experience, do you feel there is a 
relationship between how much water you drink and the pain and 
severity of your crisis? 
 
Rest, maintaining neutral body temperature and hydration were the top three self-care actions 
respondents took to prevent a pain crisis (Figure 11). 
 
Figure 11. What actions do you take to prevent pain crisis from occurring? 
Medication and hydration were the primary self-care actions respondents take once to reduce the 
severity of a crisis (Figure 12). 
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Figure 12. Once you get an early warning that a pain crisis might 
occur, what actions do you take to prevent a full-blown crisis or 
reduce the severity of a full-blown pain crisis? 
 
Medication and hydration were also strategies used by respondents to resolve a crisis (Figure 
13).  
 
Figure 13. Once you are experiencing a full-blown pain crisis, 
what actions do you take to resolve the crisis? 
 
Participants identified a number of signals, symptoms or signs a wearable monitoring device 
should include, ranging from oxygen saturation to hemoglobin levels, no predominant symptom 
emerged from the responses (Figure 14).  
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Figure 14. What signals, symptoms or signs you would want the 
technology monitor 
 
The majority of respondents reported that they did not perceive any barriers to continuously 
wearing a monitoring technology (Figure 15).  
 
 
 
 
 
 
Figure 15. What daily tasks might prevent you from wearing a 
SCD monitoring technology, such as a shirt, wristband, or watch? 
 
If a monitoring technology provide an early warning of an approaching pain crisis, respondents 
reported that they would primarily rest and hydrate to avert the crisis (Figure 16). 
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Figure 16. If a wearable technology were able to warn you of an 
approaching crisis what actions might you take to prevent the 
crisis? 
 
Discussion 
Personal physiologic monitoring devices, such as the Apple watch ™, monitor an 
increasing number of parameters, and may become an important tool in patients’ self-care. This 
study was designed better under SCD patient perspectives about (1) signs and symptoms adults 
with SCD associate with an emerging pain crisis; (2) self-care strategies adults with SCD use to 
mitigate a crisis; and (3) explore individuals with SCD interest in using wearable technology to 
monitor their health status. Results from this cross-sectional survey of adults with SCD indicated 
that participants link hydration status to the frequency, severity, and duration of sickle cell pain 
crisis. Participants identified a number of physiologic parameters a personal device should 
monitor and indicated a willingness to use a device for self-monitoring. The relationship between 
hydration status and sickle cell pain crisis is well established (Brugnara, 1995; Trippette, J., 
Loko, G., & Samb, A, 2010; Okomo & Meremikwi, 2015; Diaw,
 
samb,
 
Diop,
 
Sall, Ba,
 
Cissé,
 
Connes, 2014), therefore, accurate assessment of hydration levels may provide an opportunity to 
resolve dehydration early, thereby reducing the severity of sickle cell pain crises.  
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Research notes that early intervention with hydration, pain medication, relaxation 
techniques greatly influence pain severity. Not only did the majority of survey participants state 
that maintaining hydration is a primary pain prevention technique, they also linked improved 
hydration to lessening the impact of symptoms and hastening resolution of the crisis. Further, the 
majority of respondents would take steps to improve their hydration if a monitoring device 
warned them about a developing crisis.  
Participants expressed enthusiasm for a devise to help monitor their disease and alert 
others that they are facing physiological decline and are in pain. The majority reported there was 
no barrier for them using such a devise. As technology continues to develop, innovation such as 
glucose monitoring adhesive patches for diabetes, heart arrhythmia monitoring for heart 
conditions, and exposure to ultraviolet light provide new opportunities for disease management 
and complication prevention. Further, data gathered from these devices can be shared with both 
providers and patients and may lead to more informed diagnosis and tailored, effective treatment. 
Although the results of this study are preliminary, findings suggest that the patient “P” in the 
Three P’s model view SCD hydration monitoring favorably.   
Limitations 
 The most significant limitation to this study was the small sample size. It may be that 
members of OneSCDVoice receive many requests for study participation and thus were not 
interested in participation. They also may not have valued student-led research.  7 of 14 
participants who launch the survey did not complete it. Barriers to survey completion may have 
included the open-ended nature of the questions or the format of the survey, spread out across 
three pages. Future surveys might include multiple choice options or be contained on a single 
page. The timing of the recruitment posts might also have impacted participation since more 
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participants responded to posts on Fridays and weekends, then on Monday. It may be that there 
were less time constraints on the weekend. The survey questions were designed to elicit short 
answers, future research should consider semi-structured interviews or focus groups as these 
methods provide more opportunity for in depth exploration of participant experiences (Kim, 
Sefcik, & Bradway, 2016). Since hydration monitoring is an emerging innovation, there were no 
specific hydration monitoring devices to share with participants. Using available, and approved, 
technologies would provide a more comprehensive product to discuss with patients compared to 
discussing hypothetical technologies.  
Conclusion 
 SCD is a prevalent, chronic, life limiting, genetic, medical condition effecting a large 
population of the United States. New monitoring technologies offer the potential to lessen 
patients’ disease burden as well as reduce healthcare system expense, morbidity, and mortality. 
Findings from this study offer encouraging evidence of interest in self-monitoring by individuals 
with SCD and a willingness to enact self-care strategies in response to self-monitoring feedback.  
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